טוען...
Bayesian survival analysis for early detection of treatment effects in phase 3 clinical trials
Despite appealing characteristics for the clinical trials setting, Bayesian inference methods remain scarcely used, especially in randomized controlled clinical trials (RCT). This is particularly true when dealing with a survival endpoint, likely due to the additional complexities to model specifica...
שמור ב:
הוצא לאור ב: | Contemp Clin Trials Commun |
---|---|
Main Authors: | , , , |
פורמט: | Artigo |
שפה: | Inglês |
יצא לאור: |
Elsevier
2021
|
נושאים: | |
גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7817368/ https://ncbi.nlm.nih.gov/pubmed/33511301 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.conctc.2021.100709 |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|